Point72 (Difc) LTD Biomea Fusion, Inc. Transaction History

Point72 (Difc) LTD

$2.72 Trillion
Q4 2024

A detailed history of Point72 (Difc) LTD transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 7,408 shares of BMEA stock, worth $27,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,408

Holding current value

$27,631

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$3.88 - $12.41 $28,743 - $91,933	7,408 New	7,408 $28.7 Million
Q2 2024 Aug 14, 2024	BUY	$4.14 - $15.3 $19,797 - $73,164	4,782 New	4,782 $21.5 Million

Others Institutions Holding BMEA

# of Institutions

118

Shares Held

19.1M

Call Options Held

1.84M

Put Options Held

682K

Cormorant Asset Management, LP Boston, MA

3.57M
Shares

$13.3 Million
1.09% of portfolio
Black Rock Inc. New York, NY

2.34M
Shares

$8.75 Million
0.0% of portfolio
Baker Bros. Advisors LP New York, NY

1.45M
Shares

$5.42 Million
0.06% of portfolio
Vanguard Group Inc Valley Forge, PA

1.4M
Shares

$5.23 Million
0.0% of portfolio
Aisling Capital Management LP New York, NY

799K
Shares

$2.98 Million
1.14% of portfolio

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $109M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.

Account